NewSquare Capital’s Allergan plc AGN Stock Holding History

NewSquare Capital’s Portfolio AGN Stock Details AGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-45	Closed	-$7K	–	353
2017 Q4	$7K	Hold	45	–	–	﹤0.01%	250
2017 Q3	$9K	Hold	45	–	–	﹤0.01%	221
2017 Q2	$11K	Hold	45	–	–	﹤0.01%	190
2017 Q1	$11K	Buy	+45	New	+$10.5K	﹤0.01%	192
2016 Q4	–	Sell	-19	Closed	-$4K	–	482
2016 Q3	$4K	Buy	+19	New	+$4.64K	﹤0.01%	363
2016 Q2	–	Sell	-184	Closed	-$49K	–	416
2016 Q1	$49K	Buy	184 +169	+1,127%	+$48.4K	0.01%	168
2015 Q4	$5K	Hold	15	–	–	﹤0.01%	273
2015 Q3	$4K	Hold	15	–	–	﹤0.01%	263
2015 Q2	$5K	Hold	15	–	–	﹤0.01%	270
2015 Q1	$4K	Hold	15	–	–	﹤0.01%	250
2014 Q4	$4K	Hold	15	–	–	﹤0.01%	258
2014 Q3	$4K	Buy	+15	New	+$3.36K	﹤0.01%	272

Other funds holding AGN

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Edgewood Management Greenwich, Connecticut $15.5B AUM 9.67% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Baupost Group Boston, Massachusetts $5.12B AUM 15.99% 1-Year Est. Return

NewSquare Capital's AGN Position: Q1 2018 in Review

NewSquare Capital sold out of Allergan plc (AGN) in Q1 2018, closing a stake of 45 shares — an estimated $7K sold.

NewSquare Capital first reported a position in AGN in Q3 2014 and held it in 12 quarters. The position peaked at $49K in Q1 2016. 1,022 funds tracked by Wall St. Rank hold AGN as of Q1 2018.

NewSquare Capital reported no remaining Allergan plc position as of Q1 2018 after selling out during the quarter.
NewSquare Capital sold 45 Allergan plc shares in Q1 2018, an estimated $7K.
NewSquare Capital first reported a position in Allergan plc in Q3 2014 and held it in 12 quarters.
NewSquare Capital's Allergan plc position peaked at $49K in Q1 2016.
1,022 funds tracked by Wall St. Rank held Allergan plc as of Q1 2018.

Based on NewSquare Capital's 13F filing for Q1 2018, filed 24 Apr 2018.